NASDAQ: BOLD
Boundless Bio, Inc.
Healthcare · Biotechnology
After hours: $2.78(0%) · as of 7:34 PM ET
Market Cap
$62.48M
52w High
$2.97
52w Low
$0.96
P/E
-0.97
Volume
251.25K
Outstanding Shares
22.47M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 148.21% over the last year. Free cash flow declined 0.87% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive shift in revenue or cash flow over the next period would be the clearest signal to resolve the ambiguity.
Company profile
Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
6
Buy
13
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est -$0.56 · Revenue est —
View